Luisa Ugedo

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition

Luisa Ugedo, Johan Grenhoff, T.H. Svensson · Psychopharmacology · 1989 · 267 citations

Psychiatry, Medicine, Neurotransmitter +12

Modulation of Anxiety-Like Behavior and Morphine Dependence in CREB-Deficient Mice

Olga Valverde, Theo Mantamadiotis, Marı́a Torrecilla et al. · Neuropsychopharmacology · 2004 · 119 citations · Full text

Psychoactive Drug, Molecular Neuroscience, Psychiatry +13

Intranasal Administration of Chitosan-Coated Nanostructured Lipid Carriers Loaded with GDNF Improves Behavioral and Histological Recovery in a Partial Lesion Model of Parkinson's Disease

Oihane Gartziandia, Enara Herrán, José Ángel Ruíz-Ortega et al. · Journal of Biomedical Nanotechnology · 2016 · 92 citations

Nanoparticles, Nanotherapeutics, Engineering +19

Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation

Sara Hernando, Catalina Requejo, Enara Herrán et al. · Neurobiology of Disease · 2018 · 90 citations · Full text

Metabolic Syndrome, Lipid Synthesis, Beneficial Effects +9

Firing patterns of midbrain dopamine neurons: differences between A9 and A10 cells

Johan Grenhoff, Luisa Ugedo, T.H. Svensson · Acta Physiologica Scandinavica · 1988 · 84 citations